Atlas Trials

Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery

Clinical trial NCT00601913 · COMPLETED

Trial details

NCT number
NCT00601913
Sponsor
Wake Forest University Health Sciences
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2008-03-01
Primary completion
2014-10-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.